Faheez Mohamed
About
Faheez Mohamed is a scholar working on Surgery, Emergency Medicine and Reproductive Medicine.
According to data from OpenAlex, Faheez Mohamed has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 50 papers in Emergency Medicine and 26 papers in Reproductive Medicine. Recurrent topics in Faheez Mohamed's work include Intraperitoneal and Appendiceal Malignancies (61 papers), Appendicitis Diagnosis and Management (50 papers) and Ovarian cancer diagnosis and treatment (25 papers). Faheez Mohamed is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (61 papers), Appendicitis Diagnosis and Management (50 papers) and Ovarian cancer diagnosis and treatment (25 papers). Faheez Mohamed collaborates with scholars based in United Kingdom, United States and Spain. Faheez Mohamed's co-authors include Brendan Moran, Tom Cecil, Kandiah Chandrakumaran, Paul H. Sugarbaker, Norman J. Carr, Sanjeev Dayal, Leslie H. Sobin, Santiago González‐Moreno, Sara Chapman and O. Anthony Stuart and has published in prestigious journals such as Blood, British Journal of Cancer and The American Journal of Surgical Pathology.
In The Last Decade
Faheez Mohamed
64 papers receiving 2.1k citations
Hit Papers
Peers
Faheez Mohamed
Jesús Esquivel United States
Naoual Bakrin France
Pierre Jacquet United States
J. Porcheron France
Robert M. Smeenk Netherlands
Mohammad Alyami France
Jean Marc Bereder France
Daniele Biacchi Italy
Paolo Sammartino Italy
Kandiah Chandrakumaran United Kingdom
Citations per year, relative to Faheez Mohamed Faheez Mohamed (= 1×)
peers
Jesús Esquivel
Countries citing papers authored by Faheez Mohamed
Since
Specialization
Citations
This map shows the geographic impact of Faheez Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faheez Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faheez Mohamed more than expected).
Fields of papers citing papers by Faheez Mohamed
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Faheez Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faheez Mohamed. The network helps show where Faheez Mohamed may publish in the future.
Co-authorship network of co-authors of Faheez Mohamed
This figure shows the co-authorship network connecting the top 25 collaborators of Faheez Mohamed. A scholar is included among the top collaborators of Faheez Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faheez Mohamed. Faheez Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Steffens, Daniel, Cherry Koh, Nabila Ansari, et al.. (2025). International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and Australia. Diseases of the Colon & Rectum. 68(9). 1074–1084.
2.
Kusamura, Shigeki, Edward A. Levine, Michela Cinquini, et al.. (2025). Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and Recommendation. Journal of Surgical Oncology. 132(5). 810–816.
3.
Mohamed, Faheez, Khalid El Bairi, Shah Zeb Khan, et al.. (2025). Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies. European Journal of Cancer. 225. 115564–115564.
4.
Mohamed, Faheez, et al.. (2023). Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal Malignancy Centre. Indian Journal of Surgical Oncology. 14(4). 920–927.
5.
Roy, Ashok, et al.. (2023). Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study. Health Science Reports. 6(9). e1558–e1558.
6.
Chandramohan, Anuradha, et al.. (2021). Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making. Insights into Imaging. 12(1). 174–174.
7.
Godbole, Chintamani, Tom Cecil, Sanjeev Dayal, et al.. (2021). Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology. Annals of Surgical Oncology. 29(4). 2607–2613.
8.
Mason, G. Robert, Sara Burke, Tom Cecil, et al.. (2020). Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract origin. European Journal of Clinical Nutrition. 75(5). 856–858.
9.
Roy, Ashok, Savita Rangarajan, John Bell, et al.. (2019). Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei. Journal of Thrombosis and Haemostasis. 18(2). 352–363.
10.
Mohamed, Faheez, et al.. (2018). Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?. PubMed. 3(4). 20180123–20180123.
11.
Pengelly, Reuben J., Karen Pickard, Brendan Moran, et al.. (2018). Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei. Journal of Molecular Diagnostics. 20(5). 635–642.
12.
Rangarajan, Karan, Kandiah Chandrakumaran, Sanjeev Dayal, et al.. (2017). The pre-operative neutrophil–lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin. International Journal of Hyperthermia. 34(5). 559–563.
13.
Mehta, Akash, et al.. (2017). Preserving fertility in pseudomyxoma peritonei, a novel approach. PubMed. 2(1). 33–36.
14.
Mohamed, Faheez, et al.. (2016). Cytoreductive surgery with intraperitoneal chemotherapy in the management of peritoneal surface malignancy: a pharmacist's perspective. European Journal of Hospital Pharmacy. 23(4). 233–238.
15.
Kyriazanos, Ioannis, Vasileios Kalles, Anastasios Stefanopoulos, John Spiliotis, & Faheez Mohamed. (2016). Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Surgical Oncology. 25(3). 308–314.
16.
Tan, Grace Hwei Ching, Sanjeev Dayal, Kandiah Chandrakumaran, et al.. (2016). The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin. European Journal of Surgical Oncology. 43(2). 388–394.
17.
Mohamed, Faheez, Tom Cecil, Brendan Moran, & Paul H. Sugarbaker. (2011). A New Standard of Care for the Management of Peritoneal Surface Malignancy. Current Oncology. 18(2). 84–96.
18.
Mohamed, Faheez, et al.. (2011). Dukes C colorectal cancer: is the metastatic lymph node ratio important?. International Journal of Colorectal Disease. 27(3). 309–317.
19.
Mohamed, Faheez, Pierre Marchettini, O. Anthony Stuart, Dal Yoo, & Paul H. Sugarbaker. (2003). A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. European Journal of Surgical Oncology. 29(3). 261–265.
20.
Mohamed, Faheez, Pierre Marchettini, O. Anthony Stuart, & Paul H. Sugarbaker. (2003). Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions. Cancer Chemotherapy and Pharmacology. 52(5). 405–410.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jesús Esquivel Breakdown of academic impact, for papers by Naoual Bakrin Breakdown of academic impact, for papers by Pierre Jacquet Breakdown of academic impact, for papers by J. Porcheron Breakdown of academic impact, for papers by Robert M. Smeenk Breakdown of academic impact, for papers by Mohammad Alyami Breakdown of academic impact, for papers by Jean Marc Bereder Breakdown of academic impact, for papers by Daniele Biacchi Breakdown of academic impact, for papers by Paolo Sammartino Breakdown of academic impact, for papers by Kandiah Chandrakumaran